Delivery Order SPE2DB22D3501-SPE2DB25FWL61
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,054.62 firm fixed-price delivery order is for the pharmaceutical product ZORYVE 0.3% Cream, 60 GM. The contract has a period of performance through February 6, 2025 and was awarded on February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,182.21 firm fixed-price delivery order is for the supply of ZORYVE 0.3% cream in 60 gram units, with a completion date of May 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.99 firm fixed-price contract is for the delivery of ZORYVE 0.3% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,330.02 firm fixed-price delivery order is for the supply of the pharmaceutical product ZORYVE 0.3% CREAM 60GM. The contract has an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,156.39 firm fixed-price delivery order is for the supply of ZORYVE 0.3% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This federal contract award, valued at $1,627.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZORYVE 0.3% Cream (60 gm). This is a firm fixed-price delivery order contract with a completion date of March 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,149.04, is a delivery order for the medication "ZORYVE 0.3% CREAM 60GM" with an ultimate completion date of April 30, 2025. The contract is not set-aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Zoryve 0.3% cream in a 60 gram package. The $1,084.84 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 21, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $6,172.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ZORYVE 0.3% cream, a pharmaceutical product, with a period of performance through June 26, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX5JN, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% CREAM 60GM, a medical product, with a ceiling value of $6,712.54 and a completion date of November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWL61Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA), a defense agency. The $1,905.11 firm fixed price delivery order is for the supply of ZORYVE 0.3% cream, with a completion date of July 18, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This award demonstrates Amerisourcebergen's capability to meet federal procurement requirements through open competition and to fulfill diverse medical supply needs for the U.S. government's defense sector.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/17/25 |